Antagonism of 5-HT3 receptor mediated currents in murine N1E-115 neuroblastoma cells by (+)-tubocurarine
References (19)
- et al.
Blockade of neuronal tryptamine receptors by metoclopramide
Eur. J. Pharmacol.
(1978) - et al.
Pharmacological characterisation of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells
Neuropharmacology
(1988) - et al.
Divalent cations modulate 5-HT3 receptor-induced currents in N1E-115 neuroblastoma cells
Eur. J. Pharmacol.
(1988) - et al.
Electrophysiology of 5-HT3 receptors in neuronal cell lines
Trends Pharmacol.
(1989) - et al.
The action of methylated derivates of 5-hydroxytryptamine at ganglionic receptors
Neuropharmacology
(1980) - et al.
5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line
Neuron
(1988) - et al.
Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells
J. Physiol. (Lond.)
(1979) - et al.
The mode of action of antagonists of the excitatory response to acetylcholine in Aplysia neurones
J. Physiol. (Lond.)
(1978) - et al.
Pharmacological properties of GR 38032F, a novel antagonist at 5-HT3 receptors
Br. J. Pharmacol.
(1988)
Cited by (40)
Nicotinic potentiation of frog retinotectal transmission in tectum layer F by α3β2, α4β2, α2β4, α6β2, or α7 acetylcholine receptor subtypes
2015, Medicina (Lithuania)Citation Excerpt :An application of pilocarpine and oxotremorine-M, the specific muscarinic acetylcholine receptor agonists, had no effect on the retinotectal synaptic transmission. These results show that d-tubocurarine acts on the nicotinic acetylcholine receptors, not on the 5-HT3 and/or GABAA receptors [20,21]. The localization of these nicotinic acetylcholine receptors was of the presynaptic origin since the effect of d-tubocurarine was accompanied by a change (increase) in the paired-pulse facilitation.
Mapping spatial relationships between residues in the ligand-binding domain of the 5-Ht<inf>3</inf> receptor using a molecular ruler
2010, Biophysical JournalCitation Excerpt :To take full advantage of the double-mutant cycle analysis, we employed a panel of ligands with a number of defined small changes in structure. One ligand that can be altered in a number of ways is dTC, a competitive antagonist of both AChRs (19) and 5-HT3Rs (20). dTC has a 1- to 2000-fold higher affinity for the murine 5-HT3R than the human receptor, and it was shown that the regions responsible for this species difference are located in the amino terminal extracellular domain (21).
Dopaminergic excitation of the goat carotid body is mediated by the serotonin type 3 receptor subtype
2003, Respiratory Physiology and NeurobiologyPSAB-OFP, a selective α7 nicotinic receptor agonist, is also a potent agonist of the 5-HT<inf>3</inf> receptor
2002, European Journal of PharmacologyInteraction of d-tubocurarine analogs with mutant 5-HT<inf>3</inf> receptors
2002, NeuropharmacologyBicuculline antagonizes 5-HT(3A) and α2 glycine receptors expressed in Xenopus oocytes
2000, European Journal of Pharmacology